PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE TABLET Canada - English - Health Canada

pro-sitagliptin malate / metformin hydrochloride tablet

pro doc limitee - sitagliptin (sitagliptin malate); metformin hydrochloride - tablet - 50mg; 500mg - sitagliptin (sitagliptin malate) 50mg; metformin hydrochloride 500mg

PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE TABLET Canada - English - Health Canada

pro-sitagliptin malate / metformin hydrochloride tablet

pro doc limitee - sitagliptin (sitagliptin malate); metformin hydrochloride - tablet - 50mg; 850mg - sitagliptin (sitagliptin malate) 50mg; metformin hydrochloride 850mg

PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE TABLET Canada - English - Health Canada

pro-sitagliptin malate / metformin hydrochloride tablet

pro doc limitee - sitagliptin (sitagliptin malate); metformin hydrochloride - tablet - 50mg; 1000mg - sitagliptin (sitagliptin malate) 50mg; metformin hydrochloride 1000mg

Sitagliptine/Metformine Krka 50 mg - 1 000 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptine/metformine krka 50 mg - 1 000 mg film-coat. tabl.

krka d.d. novo mesto d.d. - metformin hydrochloride 1000 mg; sitagliptin 50 mg - film-coated tablet - 50 mg - 1000 mg - sitagliptin 50 mg; metformin hydrochloride 1000 mg - metformin and sitagliptin

Sitagliptine/Metformine Krka 50 mg - 850 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptine/metformine krka 50 mg - 850 mg film-coat. tabl.

krka d.d. novo mesto d.d. - sitagliptin 50 mg; metformin hydrochloride 850 mg - film-coated tablet - 50 mg - 850 mg - sitagliptin 50 mg; metformin hydrochloride 850 mg - metformin and sitagliptin

SITAGLIPTIN PHOSPHATE/METFORMIN HYDROCHLORIDE- sitagliptin and metformin hydrochloride tablet, film coated United States - English - NLM (National Library of Medicine)

sitagliptin phosphate/metformin hydrochloride- sitagliptin and metformin hydrochloride tablet, film coated

patheon puerto rico, inc. - sitagliptin phosphate (unii: ts63ew8x6f) (sitagliptin - unii:qfp0p1dv7z), metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - sitagliptin phosphate 50 mg

JANUET 50 MG1000 MG Israel - English - Ministry of Health

januet 50 mg1000 mg

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 1000 mg - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

JANUET 50 MG500 MG Israel - English - Ministry of Health

januet 50 mg500 mg

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 500 mg - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

JANUET 50 MG850 MG Israel - English - Ministry of Health

januet 50 mg850 mg

merck sharp & dohme (israel - 1996) company ltd, israel - metformin hydrochloride; sitagliptin as monohydrate phosphate - tablets - sitagliptin as monohydrate phosphate 50 mg; metformin hydrochloride 850 mg - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

Sitagliptin/Metformin Sandoz 50 mg - 850 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sitagliptin/metformin sandoz 50 mg - 850 mg film-coat. tabl.

sandoz sa-nv - sitagliptin hydrochloride monohydrate 56,685 mg - eq. sitagliptin 50 mg; metformin hydrochloride 850 mg - film-coated tablet - 50 mg - 850 mg - sitagliptin hydrochloride monohydrate 56.685 mg; metformin hydrochloride 850 mg - metformin and sitagliptin